News Image

Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia

Provided By GlobeNewswire

Last update: Nov 11, 2025

Agreement creates runway for Profound’s incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East

Read more at globenewswire.com

PROFOUND MEDICAL CORP

NASDAQ:PROF (11/17/2025, 8:10:23 PM)

6.46

-0.39 (-5.69%)



Find more stocks in the Stock Screener

Follow ChartMill for more